NCT02404675 2017-07-28
INCREASE
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
Clinical Trials
6 trialsNCT01646450 2015-09-09
First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01926171 2015-07-15
Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01720901 2015-05-22
Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy
Betta Pharmaceuticals Co., Ltd.
Phase 4 Suspended
NCT02103257 2015-04-29
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01465243 2014-02-17
Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose
Betta Pharmaceuticals Co., Ltd.
Phase 4 Completed